Ravoxertinib,2070009-58-2

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Ravoxertinib hydrochloride

CAS No. : 2070009-58-2

MCE 国际站：Ravoxertinib hydrochloride

产品活性：Ravoxertinib hydrochloride (GDC-0994 hydrochloride) 是一种可口服的 ERK 抑制剂，对 ERK1 和 ERK2 的 IC₅₀ 值分别为 6.1 nM 和 3.1 nM。

研究领域：MAPK/ERK Pathway  |  Stem Cell/Wnt

作用靶点：ERK

In Vitro: Ravoxertinib also inhibits p90RSK with IC₅₀ of 12 nM.
Ravoxertinib is highly selective for ERK1 and ERK2, with biochemical potency of 1.1 nM and 0.3 nM, respectively.
Ravoxertinib (GDC0994; 50 nM, 0.5 µM, and 5 µM; 48 hours) decreases the viability of lung adenocarcinoma cell lines (A549, HCC827, HCC4006).

In Vivo: In CD-1 mice, a 10 mg/kg oral dose of Ravoxertinib is sufficient to achieve the desired target coverage for at least 8 h. Daily, oral dosing of Ravoxertinib results in significant single-agent activity in multiple in vivo cancer models, including KRAS-mutant and BRAF-mutant human xenograft tumors in mice.

相关产品：Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Kinase Inhibitor Library  |  MAPK Compound Library  |  Stem Cell Signaling Compound Library  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Anti-Aging Compound Library  |  Reprogramming Compound Library  |  Oxygen Sensing Compound Library  |  Orally Active Compound Library  |  Glutamine Metabolism Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Anti-Obesity Compound Library  |  Angiogenesis-Related Compound Library  |  Anti-Liver Cancer Compound Library   |  Anti-Colorectal Cancer Compound Library   |  Anti-Prostate Cancer Compound Library  |  Anti-Pulmonary Fibrosis Compound Library  |  Cancer Stem Cells Compound Library  |  Heterocyclic Compound Library  |  Pain-Related Compound Library  |  Highly Selective Inhibitors Library  |  Serine/Threonine Kinase Inhibitor Library  |  PD98059  |  Yoda 1  |  SCH772984  |  TBHQ  |  Tauroursodeoxycholate  |  Ulixertinib  |  Honokiol  |  Astragaloside IV  |  Piperlongumine  |  Ravoxertinib  |  Temuterkib  |  C16-PAF  |  Lidocaine  |  FR 180204  |  BIX02189  |  XMD8-92  |  MK-8353  |  6-OAU  |  Patritumab  |  trans-Zeatin  |  SEW​2871  |  Urolithin B  |  VX-11e  |  ASN007  |  Pamoic acid  |  Pachymic acid  |  AG126  |  Lysophosphatidylcholines

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds